Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07518862) titled 'Heart Rate VAriability as a MaRker for tItrATing hIgh flOw Nasal Cannula Therapy' on April 1.

Study Type: Observational

Primary Sponsor: University Health Network, Toronto

Condition: Respiratory Failure Heart Rate Variability (HRV) High Flow Nasal Cannula

Recruitment Status: Not recruiting

Date of First Enrollment: April 2026

Target Sample Size: 20

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/study/NCT07518862

Published by HT Digital Content Services with permission from Health Daily Digest....